Coronavirus (COVID-19) Impact on Agricultural Biotechnology Market 2020: Sales, Revenue of Top Companies, Emerging...
"Agricultural Biotechnology Market"
Agricultural Biotechnology Market: Information by Crop Type (Soybean, Maize, Cotton, and others), Application (Herbicide Tolerance, Stacked Traits, Insect Tolerance, and others), Technique (Genetic Engineering, Molecular Breeding, Molecular Diagnostics and Tissue Culture)...
Hyloris Aims for €71M Euronext IPO to Reformulate Common Medications
An IPO launched on Euronext Brussels by Hyloris Pharmaceuticals will finance the Belgian company’s efforts to make approved drugs more convenient and versatile in healthcare by providing them topically or intravenously.
The target price of...
African farmers yearn for biotechnology in the face of climate change – Alliance for...
Southern Africa is on the receiving end of the devastating impact of climate change, driving millions into hunger.
A record 45 million people — mostly women and children — in the 16-nation Southern African Development...
Cancer Drug Inspired by Sea Animal Gets FDA Green Light
The Spanish company PharmaMar’s stock price has shot up by 30% as its cancer drug lurbinectedin was given accelerated approval for the second-line treatment of metastatic small cell lung cancer in the US this...
Researchers Discover Key Structures in Kidney Formation
Renal fibrosis is a direct consequence of the kidney’s limited capacity to regenerate after injury. Renal scarring results in a progressive loss of renal function, ultimately leading to end-stage renal failure and a requirement...
Blocking Newly Identified Opioid Receptor Points to New Therapeutics for Pain, Depression, and Cancer
Researchers at the Department of Infection and Immunity of the Luxembourg Institute of Health (LIH) have developed a novel molecule that binds to and blocks a previously unrecognized opioid receptor in the brain. The...
Strenuous daily exercise may shorten, not prolong, longevity
Credit: Naoyuki Hayashi, Kazuhiro Kezuka
By analyzing longevity data for professional Japanese traditional artists, researchers at Tokyo Institute of Technology (Tokyo Tech) have found that Kabuki actors,...
AFFiRiS AG announces results of phase 1 trial with PD01A in Parkinson’s
Reviewed by Emily Henderson, B.Sc.Jun 18 2020
AFFiRiS AG, a clinical-stage biotechnology company developing novel disease-modifying specific active immunotherapies (SAITs), today announced that detailed results of the phase 1 clinical program with its lead candidate...
Machine Learning Identifies Proteins Associated with Drug Side Effects
A multi-institutional group of researchers led by Harvard Medical School and the Novartis Institutes for BioMedical Research (NIBR) report that is has created an open-source machine learning tool that identifies proteins associated with drug...
BIA Separations Introduces PrimaS Multi-Mode Ligand Bioprocess Technology
Officials at BIA Separations say the company’s novel PrimaS ligand multi-use platform technology facilitates high-resolution and high-speed processing and addresses critical separation problems in the context of advanced therapy medicinal products (ATMPs). The first...
